2025
SJR Q3
JCR Q2 · 1,5
OA
260 eşleşen makale
SCIE
Dergi ayrıntısı
Tohoku Journal of Experimental Medicine
- Yayıncı
- Tohoku University Medical Press
- Ülke
- Japan · Asiatic Region
- Tür
- journal
- ISSN
-
0040872713493329
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,452
- Quartile Q3
- H-Index 74
- Atıf/yayın 1,44
- Doküman (3y) 318
- Atıf (3y) 496
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 1,5
- 5Y JIF 1,7
- JCI 0,36
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Biochemistry, Genetics and Molecular Biology (miscellaneous) Q3
- Medicine (miscellaneous) Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Medicine, General & Internal | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q2 | 0,452 | 1,5 | 1,7 | 0,36 | Q2 | 74 |
| 2024 | Q2 | Q2 | 0,46 | 1,6 | 1,7 | 0,39 | Q2 | 71 |
| 2023 | Q2 | Q2 | 0,484 | 1,7 | 1,8 | 0,41 | Q2 | 71 |
| 2022 | Q2 | Q3 | 0,505 | 2,2 | 2,1 | 0,41 | Q2 | 71 |
| 2021 | Q2 | Q3 | 0,558 | 2,5 | 2,4 | 0,46 | Q2 | 71 |
| 2020 | Q2 | Q3 | 0,514 | 1,8 | 2,1 | 0,51 | Q2 | 71 |
| 2019 | Q2 | Q3 | 0,489 | 1,4 | 1,6 | 0,53 | Q2 | 71 |
| 2018 | — | Q2 | — | 1,6 | 1,6 | 0,54 | Q2 | — |
| 2017 | Q2 | Q3 | 0,627 | 1,4 | 1,5 | 0,5 | Q2 | 71 |
| 2016 | Q2 | Q3 | 0,584 | 1,3 | 1,4 | — | — | 71 |
| 2015 | Q2 | Q2 | 0,588 | 1,3 | 1,5 | — | — | 71 |
| 2014 | Q2 | Q2 | 0,569 | 1,4 | 1,4 | — | — | 71 |
| 2013 | Q2 | Q2 | 0,558 | 1,3 | 1,4 | — | — | 71 |
| 2012 | Q2 | Q2 | 0,563 | 1,4 | 1,4 | — | — | 71 |
| 2011 | Q2 | Q2 | 0,495 | 1,2 | 1,3 | — | — | 71 |
| 2010 | Q2 | Q2 | 0,471 | 1,1 | 1,2 | — | — | 71 |
| 2009 | — | Q2 | — | 1,3 | 1,2 | — | — | — |
| 2008 | — | Q3 | — | 1,3 | 1,2 | — | — | — |
| 2007 | — | Q3 | — | 1,1 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 1 | — | — | — | — |
| 2005 | — | Q3 | — | 0,9 | — | — | — | — |
| 2004 | — | Q3 | — | 0,7 | — | — | — | — |
| 2003 | — | Q4 | — | 0,4 | — | — | — | — |
| 2002 | — | Q3 | — | 0,5 | — | — | — | — |
| 2001 | — | Q3 | — | 0,5 | — | — | — | — |
| 2000 | — | Q4 | — | 0,3 | — | — | — | — |
| 1999 | — | Q3 | — | 0,4 | — | — | — | — |
| 1998 | — | Q3 | — | 0,4 | — | — | — | — |
| 1997 | — | Q4 | — | 0,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 148/336 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 146/191 |
| 2024 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 124/332 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 142/195 |
| 2023 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 117/329 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 135/189 |
| 2022 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 104/169 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 106/136 |
| 2021 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 99/172 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 111/139 |
| 2020 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 102/167 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 116/140 |
| 2019 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 95/165 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 118/139 |
| 2018 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 80/160 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 104/136 |
| 2017 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 84/155 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 107/133 |
| 2016 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 80/155 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 99/128 |
| 2015 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 75/155 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 94/124 |
| 2014 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 72/154 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 94/123 |
| 2013 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 78/156 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 92/124 |
| 2012 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 66/155 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 83/121 |
| 2011 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 70/155 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 77/112 |
| 2010 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 75/153 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 78/106 |
| 2009 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 63/133 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 66/93 |
| 2008 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 60/107 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 61/83 |
| 2007 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 58/100 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 65/81 |
| 2006 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 57/103 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 60/76 |
| 2005 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 56/105 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 56/72 |
| 2004 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 60/103 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 59/71 |
| 2003 | MEDICINE, GENERAL & INTERNAL | SCIE | Q4 | — | 80/102 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 68/72 |
| 2002 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 73/107 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 68/74 |
| 2001 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 67/112 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 62/75 |
| 2000 | MEDICINE, GENERAL & INTERNAL | SCIE | Q4 | — | 81/105 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 69/74 |
| 1999 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 68/110 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 65/76 |
| 1998 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 59/107 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 53/72 |
| 1997 | MEDICINE, GENERAL & INTERNAL | SCIE | Q4 | — | 82/100 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 57/61 |